TG Therapeutics Inc (TGTX) valuation · P/E 20, rev $616.3M
TG Therapeutics Inc (TGTX) P/E 20, rev $616.3M.
| Metric | Value |
|---|---|
| P/E | 20 |
| Market cap | $7.88B |
| Revenue | $616.3M |
| P/S | 12.8 |
| P/B | 13.5 |
TGTX valuation FAQ
What is TGTX's P/E ratio?
TG Therapeutics Inc (TGTX) trailing P/E is 20 on the latest cached fundamentals snapshot.
What is TGTX's market cap?
TG Therapeutics Inc (TGTX) market cap is $7.88B on the latest cached fundamentals snapshot.
What is TGTX's latest revenue?
Latest cached TG Therapeutics Inc (TGTX) revenue was $616.3M. Statements: https://lician.com/financials/tgtx
What is TGTX's price-to-sales ratio?
TG Therapeutics Inc (TGTX) price-to-sales (P/S) is 12.8, cached market cap $7.88B divided by revenue $616.3M.
What is TGTX's price-to-book ratio?
TG Therapeutics Inc (TGTX) price-to-book (P/B) is 13.5 on the latest cached fundamentals snapshot.
How many TGTX valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for TG Therapeutics Inc (TGTX): P/E, Market cap, Revenue, P/S, and P/B.
Where is TGTX valuation listed?
Cached valuation multiples for TG Therapeutics Inc (TGTX) are listed at https://lician.com/valuation/tgtx.
Not investment advice. Cached rows, not a live tape.